Skip to main content

Table 1 Patient characteristics (n = 105)

From: Comparison of palonosetron, granisetron, and ramosetron for the prevention of postoperative nausea and vomiting after laparoscopic gynecologic surgery: a prospective randomized trial

 

Palonosetron group, n = 35

Granisetron group, n = 35

Ramosetron group, n = 35

P-value

Age, year

51.5 ± 16.3

52.5 ± 15.7

48.2 ± 12.1

0.42

Height (cm)

155.3 ± 3.1

157.1 ± 6.1

157.2 ± 3.3

0.65

Weight (kg)

60.1 ± 4.9

59.3 ± 5.1

56.3 ± 4.3

0.55

Operation Time(min)

100.2 ± 34.1

99.4 ± 25.3

92.6 ± 24.9

0.46

Anesthesia Time(min)

128.1 ± 47.5

123.5 ± 35.1

120.1 ± 23.0

0.63

Fluid Admin(mL)

522.1 ± 61.2

644 ± 33.3

538 ± 53.9

0.75

ASA class I/II

23/12

24/11

26/9

0.67

Comorbid dis.

   

0.56

 Hypertension

7

8

8

 

 Diabetes

3

3

4

 

 Othera

1

0

1

 
  1. aOther comorbid diseases include: Fatty liver, Rheumatoid arthritis